Stock screenerAll disclosures →
EDGAR →
ULS
Conviction 42HealthcareScan · Mon, Aug 10, 2026Falling three methods
ULS$78.03-0.23%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.71M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price78.03
Change-0.23%
Gap+0.05%
Rel volume8.01×
Avg volume1.4M
Avg $ vol115.47M
SMA 2086.07
SMA 5091.35
SMA 20085.69
Price vs 50-14.58%
Price vs 200-8.94%
MA stackmixed
50/200 cross—
Supertrenddown · 89.05
RSI (14)32
MACD hist-1.06
MACD crossbear · 4d
Stoch %K / %D15 / 13
ADX (14)26
+DI / −DI14 / 33
RSI divergenceBullish
MACD divergenceBullish
ATR %+4.64%
ADR %3.79%
52w high104.89
52w low62.63
From 52w high-25.61%
Above 52w low+24.59%
New 52w highNo
SqueezeOff
Bollinger width23.75%
%B0.11
Donchian pos14.72%
Donchian high93.61
Donchian low75.34
AVWAP (52w high)91.44
vs AVWAP high-14.67%
AVWAP (52w low)82.84
vs AVWAP low-5.80%
OBV trendDown
Chaikin MF (20)-0.20
Today vs 20d8.01×
Avg vol (14d)1.71M
Avg vol (20d)1.4M
Avg $ vol (20d)115.47M
Market cap15.69B
RS 3m (vs SPY)-27.02%
RS 6m (vs SPY)-1.32%
RS line new highNo
Trend template3/8
Technical rank29.9
1 week-14.30%
1 month-10.59%
3 months-22.31%
6 months+9.15%
1 year+18.28%
YTD-3.56%
P/E48.26
P/B9.83
P/S5.14
P/FCF38.92
EPS1.60
Div yield0.66%
ROE20.38%
ROA10.42%
Debt/Eq0.19
Current1.42
EV/EBITDA21.91
Gross margin—
Net margin10.65%
Rev growth6.38%
EPS growth-0.31%
Price target94.85
Target upside21.56%
Analyst ratingBuy
Institutional124.84%
Ent. value15.55B
Revenue816M
Net income246M
Gross profit—
Free cash flow403M
IndustrySERVICES-TESTING LABORATORIES
ExchangeNYSE
Shares out77.81M
Employees14.85K
ListedFri, Apr 12, 2024
Free float76.21M
Float %98.6%
Short interest4.36M
Days to cover4.1d
Short volume53.6%
Squeeze score56 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.50 vs $0.52
Last surprise-3.9% miss
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank29.9 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmFalling three methods
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ULS
No recent disclosed trades by Congress in ULS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ULS · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
THAMAN MICHAEL H Director · Deferred Stock Units · 2026-07-06 | Grant | 340 | — | 2026-07-06 | 2026-07-08 |
Kini Vikram Director · Deferred Stock Units · 2026-07-06 | Grant | 213 | — | 2026-07-06 | 2026-07-08 |
PEPPING KAREN K Senior VP & CAO · Class A Common Stock · 2026-06-09 | Sell | 725 | $71K | 2026-06-09 | 2026-06-10 |
D'Angelo Scott EVP, CLO & Corporate Secy · Restricted Stock Units · 2026-06-08 | Grant | 4 | $0 | 2026-06-08 | 2026-06-10 |
Hooper Charles W Director · Deferred Restricted Stock Units · 2026-06-08 | Grant | 4 | $0 | 2026-06-08 | 2026-06-10 |
Scanlon Jennifer F. President and CEO · Restricted Stock Units · 2026-06-08 | Grant | 32 | $0 | 2026-06-08 | 2026-06-10 |
Torstad Elisabeth Director · Deferred Restricted Stock Units · 2026-06-08 | Grant | 3 | $0 | 2026-06-08 | 2026-06-10 |
SUSMAN SALLY Director · Deferred Restricted Stock Units · 2026-06-08 | Grant | 7 | $0 | 2026-06-08 | 2026-06-10 |
Uggetti Alberto EVP & CCO · Restricted Stock Units · 2026-06-08 | Grant | 2 | $0 | 2026-06-08 | 2026-06-10 |
Scanlon Jennifer F. President and CEO · Restricted Stock Units · 2026-06-08 | Grant | 54 | $0 | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in ULS · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.